Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Thibault Geoui

Thibault Geoui


About the author: Thibault has been working for over 10 years in the life-sciences industry. He studied Sciences because he likes to understand how things work, he then moved into the biotech industry to see amazing discoveries translated into real-life applications. As an academic researcher in nanobiology, Thibault contributed to the first structural genomics program on the Epstein-Barr Virus (EBV), which resulted in 3 publications in international peer reviewed journals. He worked as a global product manager at QIAGEN where he launched over 30 laboratory products, improving the productivity of protein-scientists in Academia, and in the Pharma/Biotech industry. Thibault joined Elsevier in 2011; as director of solutions marketing he manages a portfolio of online products including Reaxys, the flagship chemistry solution. Thibault has a critical impact on the product roadmap, he believes in data and market research to drive product development and to uncover what will deliver real customer-value. He is currently working on a project that will re-defined how chemists use information solutions … stay tuned!

Posts by Thibault Geoui

Introducing e-Therapeutics: An In Silico Drug Discovery Lab

Posted on May 1st, 2017 in Chemistry

When laypeople think of drug development, they almost certainly imagine clinical labs filled with chemistry and biology labware or trials with control and test groups receiving different doses of the proposed new treatments. (more…)

Making Precision Medicine a Reality

Posted on April 24th, 2017 in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative (more…)

The Costs of Irreproducible Biomedical Research

Posted on November 28th, 2016 in Pharma R&D


Issues with reproducibility plague basic biomedical research. In a June 2015 study published in PLoS Biology, the authors suggested that U.S. researchers spend $28 billion a year on research that is irreproducible. (more…)

Getting to Chemistry Breakthroughs Faster

Posted on October 17th, 2016 in Chemistry

What matters the most to scientific researchers? While there may be many answers to that question, one that stands out is the ability to better humanity through scientific discovery.  (more…)

  1. 1
  2. 2
  3. 3
  4. 6